EUVIMEDEUVIMED entdecken
Crossref

L26/P-407 Anti-Müllerian hormone predicts in vitro maturation outcomes but not primordial follicle in girls with β-thalassemia undergoing fertility preservation

W. Zhao, L. Jingjie

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von W. Zhao und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question The correlation of serum anti-Müllerian hormone with primordial follicle density and in vitro maturation outcomes in pediatric and adolescent ovarian tissue cryopreservation for fertility preservation. Summary answer AMH didn’t correlate with PFD, but positively correlation with IVM outcomes,where each 1ng/mL increase raised oocyte yield by 14% and maturation rate by 3.5%. What is known already Serum AMH is an established biomarker of ovarian reserve, particularly for reflecting the number of antral follicles. However, its utility as a direct marker for the primordial follicle pool remains uncertain due to limited data, especially in specific patient subgroups such as children and adolescents. Study design, size, duration This was a retrospective cohort study analyzing data from 119 pediatric and adolescent girls who underwent OTC and IVM between July 2021 and February 2025. Participants/materials, setting, methods The study included 119 girls with transfusion-dependent thalassemia (TDT) undergoing FP before hematopoietic stem cell transplantation. Preoperative serum AMH levels were measured. Ovarian cortical tissue was obtained for OTC, with a small fraction analyzed histologically to quantify PFD. Immature oocytes collected from the tissue underwent IVM. We used multivariate regreTHE ssion analyses to assess the correlation between serum AMH levels, PFD, oocyte yield, and oocyte maturation rates. Main results and the role of chance The median preoperative serum AMH level was 3.1 ng/mL (interquartile range: 1.9–4.4 ng/mL). Multivariate regression analyses revealed that serum AMH levels were not significantly correlated with PFD (β = −0.04, 95% confidence interval [CI]: −0.12 to 0.03, P = 0.262). However, higher AMH levels were significant independent predictors of increased oocyte yield (Incidence Rate Ratio [IRR]: 1.14, 95% CI: 1.08–1.20; P < 0.001) and improved maturation rates of IVM (β = 3.50, 95% CI: 1.10–5.90; P= 0.005). Furthermore, older age was significantly correlated with lower PFD (β = −0.07, 95% CI: −0.13 to − 0.01, P = 0.032) and associated with increased oocyte retrieval (IRR: 1.06, 95% CI: 1.02–1.11; P = 0.008) and improved maturation rates (β = 2.52, 95% CI: 0.54–4.51; P = 0.013). Limitations, reasons for caution:Limitations include the retrospective design and specific TDT population, limiting generalizability. The AMH-PFD dissociation suggests AMH should be used cautiously when counseling TDT pediatric/adolescent patients regarding their underlying primordial follicle reserve and future fertility potential. Wider implications of the findings For children and adolescents undergoing FP, AMH is associated with oocyte and the maturation of IVM rates. However, it should not be used as a direct surrogate for the primordial follicle pool within the cryopreserved ovarian tissue . Trial registration number No

Zitieren

APA

Zhao, W., & Jingjie, L. (2026). L26/P-407 Anti-Müllerian hormone predicts in vitro maturation outcomes but not primordial follicle in girls with β-thalassemia undergoing fertility preservation. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.741

Vancouver

Zhao W, Jingjie L. L26/P-407 Anti-Müllerian hormone predicts in vitro maturation outcomes but not primordial follicle in girls with β-thalassemia undergoing fertility preservation. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.741

BibTeX
@article{Zhao2026,
  author = {Zhao, W. and Jingjie, L.},
  title = {L26/P-407 Anti-Müllerian hormone predicts in vitro maturation outcomes but not primordial follicle in girls with β-thalassemia undergoing fertility preservation},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.741}
}
Kostenlos starten →